Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 2/20 | 0.42 |
| ▸ | ACVRL1 | P37023 | 8/20 | 0.36 |
| ▸ | TNK2 | Q07912 | 5/20 | 0.36 |
| ▸ | ADA | P00813 | 1/20 | 0.33 |
| ▸ | INSR | P06213 | 1/20 | 0.32 |
| ▸ | IGF1R | P08069 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13519782 | 0.88 | ADORA2A (0.44) | ADORA2AACVRL1TNK2ADAPIK3CD | |
| SCHEMBL13531953 | 0.87 | ADORA2A (0.43) | ADORA2AACVRL1TNK2ADAPIK3CD | |
| SCHEMBL7598953 | 0.86 | ADORA2A (0.43) | ADORA2AACVRL1TNK2ADAPIK3CD | |
| SCHEMBL13519842 | 0.86 | ADORA2A (0.43) | ADORA2AACVRL1TNK2ADAPIK3CD | |
| SCHEMBL646044 | 0.86 | ADORA2A (0.43) | ADORA2AACVRL1PIK3CD | |
| SCHEMBL13531963 | 0.86 | ADORA2A (0.43) | ADORA2AACVRL1ADA | |
| SCHEMBL645160 | 0.86 | ADORA2A (0.43) | ADORA2AACVRL1TNK2 | |
| SCHEMBL644948 | 0.84 | ADORA2A (0.41) | ADORA2AACVRL1TNK2ADAPIK3CD | |
| SCHEMBL13519808 | 0.84 | ADORA2A (0.41) | ADORA2AACVRL1TNK2ADA | |
| SCHEMBL647116 | 0.84 | ADORA2A (0.41) | ADORA2AACVRL1TNK2ADA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2535345-A1 | Anticancer nucleoside analogs | BioCryst Pharmaceuticals, Inc. (US) | 2012-12-19 | — | — | EP | disclosed |